Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 16:12:118.
doi: 10.1186/1471-2334-12-118.

"Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate

Ulrich Sagel  1 , Alexander Krämer, Rafael T Mikolajczyk
Affiliations

"Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate

Ulrich Sagel et al. BMC Infect Dis. .

Abstract

Recent studies from Austria, France and Italy have shown that there is a poor adherence to the screening scheme for maternal Toxoplasma infections in pregnancy demonstrated by the fact that many recommended examinations are missed. This leads to undetected infections and limits our knowledge of incidence of the disease. We discuss the negative consequences of this situation on research on treatment effectiveness and the outcomes of congenital toxoplasmosis. The responsible public health institutions should assume responsibility for appropriate surveillance of the screening programme and take measures to improve screening adherence during pregnancy. Screening should start as early as possible in pregnancy and the latest test should be done at delivery. Screening schedule should allow distinguishing infections from the first, second and third trimester of pregnancy, as the risk of materno-foetal transmission and outcomes in case of foetal infections varies by time.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Remington JS, McLeod R, Thulliez P, Desmonts G. In: Infectious Diseases of the Fetus and the Newborn Infant. 6. Remington JS, Klein JO, Wilson CB, Baker CJ, editor. Elsevier Saunders, Philadelphia; 2006. Toxoplasmosis; pp. 947–1091.
    1. Bénard A, Petersen E, Salamon R, Chêne G, Gilbert R, Salmi LR. et al.The European Toxo Prevention Study Group: Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Eurosurveill. 2008;13(15):pii=18834. [cited 2010 Aug 7. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18834] - PMC - PubMed
    1. Leroy V, Raeber P-A, Petersen E, The European Toxo Prevention Study Group. National public health policies and routines programs to prevent congenital Toxoplasmosis [Unpublished report]. Bordeaux (France) 2005. [cited 2010 Aug 7 http://eurotoxo.isped.u-bordeaux2.fr/]
    1. Aspöck H, Pollak A. Prevention of Prenatal Toxoplasmosis by Serological Screening of Pregnant Women in Austria. Scand J Infect Dis. 1992. pp. 32–38. - PubMed
    1. Petersen E, Remmer Schmidt D. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Expert Rev Anti-infect Ther. 2003;1:175–182. doi: 10.1586/14787210.1.1.175. - DOI - PubMed